Selected research
Industry Research
Mycology Immunoassays Testing Industry Research Report 2026
Market perspective
The global Mycology Immunoassays Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Mycology Immunoassays Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Mycology Immunoassays Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Mycology Immunoassays Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Mycology Immunoassays Testing include Abbott, Roche, CapitalBio Corporation, Autobio Diagnostics CO.,Ltd., Siemens, Ortho-Clinical Diagnostics, MiraVista Diagnostics, ELITechGroup and bioMérieux and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Mycology Immunoassays Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Mycology Immunoassays Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mycology Immunoassays Testing Market by Company
Abbott
Roche
CapitalBio Corporation
Autobio Diagnostics CO.,Ltd.
Siemens
Ortho-Clinical Diagnostics
MiraVista Diagnostics
ELITechGroup
bioMérieux
Beckman Coulter
Mycology Immunoassays Testing Segment by Type
ELISA
ELISPOT
Polymerase Chain Reaction (PCR)
Rapid Tests
Mycology Immunoassays Testing Segment by Application
Hospitals
Blood Banks
Others
Mycology Immunoassays Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycology Immunoassays Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mycology Immunoassays Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycology Immunoassays Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Mycology Immunoassays Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ELISA
- ELISPOT
- Polymerase Chain Reaction (PCR)
- Rapid Tests
Applications
- Hospitals
- Blood Banks
- Others
Companies covered
- Abbott
- Roche
- CapitalBio Corporation
- Autobio Diagnostics CO.,Ltd.
- Siemens
- Ortho-Clinical Diagnostics
- MiraVista Diagnostics
- ELITechGroup
- bioMérieux
- Beckman Coulter
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Mycology Immunoassays Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 ELISA
- 2.2.3 ELISPOT
- 2.2.4 Polymerase Chain Reaction (PCR)
- 2.2.5 Rapid Tests
- 2.3 Mycology Immunoassays Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Blood Banks
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Mycology Immunoassays Testing Breakdown Data by Type
- 3.1 Global Mycology Immunoassays Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Mycology Immunoassays Testing Forecasted Market Size by Type (2027-2032)
4 Mycology Immunoassays Testing Breakdown Data by Application
- 4.1 Global Mycology Immunoassays Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Mycology Immunoassays Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Mycology Immunoassays Testing Market Perspective (2021-2032)
- 5.2 Global Mycology Immunoassays Testing Growth Trends by Region
- 5.2.1 Global Mycology Immunoassays Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Mycology Immunoassays Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Mycology Immunoassays Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Mycology Immunoassays Testing Market Dynamics
- 5.3.1 Mycology Immunoassays Testing Industry Trends
- 5.3.2 Mycology Immunoassays Testing Market Drivers
- 5.3.3 Mycology Immunoassays Testing Market Challenges
- 5.3.4 Mycology Immunoassays Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Mycology Immunoassays Testing Players by Revenue
- 6.1.1 Global Top Mycology Immunoassays Testing Players by Revenue (2021-2026)
- 6.1.2 Global Mycology Immunoassays Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Mycology Immunoassays Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Mycology Immunoassays Testing Head Office and Area Served
- 6.4 Global Mycology Immunoassays Testing Players, Product Type & Application
- 6.5 Global Mycology Immunoassays Testing Manufacturers Established Date
- 6.6 Global Mycology Immunoassays Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Mycology Immunoassays Testing Market Size (2021-2032)
- 7.2 North America Mycology Immunoassays Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 7.4 North America Mycology Immunoassays Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Mycology Immunoassays Testing Market Size (2021-2032)
- 8.2 Europe Mycology Immunoassays Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 8.4 Europe Mycology Immunoassays Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Mycology Immunoassays Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Mycology Immunoassays Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Mycology Immunoassays Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Mycology Immunoassays Testing Market Size (2021-2032)
- 10.2 South America Mycology Immunoassays Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 10.4 South America Mycology Immunoassays Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Mycology Immunoassays Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Mycology Immunoassays Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Mycology Immunoassays Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Mycology Immunoassays Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.1.4 Abbott Mycology Immunoassays Testing Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 Roche
- 12.2.1 Roche Company Information
- 12.2.2 Roche Business Overview
- 12.2.3 Roche Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.2.4 Roche Mycology Immunoassays Testing Product Portfolio
- 12.2.5 Roche Recent Developments
- 12.3 CapitalBio Corporation
- 12.3.1 CapitalBio Corporation Company Information
- 12.3.2 CapitalBio Corporation Business Overview
- 12.3.3 CapitalBio Corporation Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.3.4 CapitalBio Corporation Mycology Immunoassays Testing Product Portfolio
- 12.3.5 CapitalBio Corporation Recent Developments
- 12.4 Autobio Diagnostics CO.,Ltd.
- 12.4.1 Autobio Diagnostics CO.,Ltd. Company Information
- 12.4.2 Autobio Diagnostics CO.,Ltd. Business Overview
- 12.4.3 Autobio Diagnostics CO.,Ltd. Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.4.4 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Product Portfolio
- 12.4.5 Autobio Diagnostics CO.,Ltd. Recent Developments
- 12.5 Siemens
- 12.5.1 Siemens Company Information
- 12.5.2 Siemens Business Overview
- 12.5.3 Siemens Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.5.4 Siemens Mycology Immunoassays Testing Product Portfolio
- 12.5.5 Siemens Recent Developments
- 12.6 Ortho-Clinical Diagnostics
- 12.6.1 Ortho-Clinical Diagnostics Company Information
- 12.6.2 Ortho-Clinical Diagnostics Business Overview
- 12.6.3 Ortho-Clinical Diagnostics Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.6.4 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Product Portfolio
- 12.6.5 Ortho-Clinical Diagnostics Recent Developments
- 12.7 MiraVista Diagnostics
- 12.7.1 MiraVista Diagnostics Company Information
- 12.7.2 MiraVista Diagnostics Business Overview
- 12.7.3 MiraVista Diagnostics Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.7.4 MiraVista Diagnostics Mycology Immunoassays Testing Product Portfolio
- 12.7.5 MiraVista Diagnostics Recent Developments
- 12.8 ELITechGroup
- 12.8.1 ELITechGroup Company Information
- 12.8.2 ELITechGroup Business Overview
- 12.8.3 ELITechGroup Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.8.4 ELITechGroup Mycology Immunoassays Testing Product Portfolio
- 12.8.5 ELITechGroup Recent Developments
- 12.9 bioMérieux
- 12.9.1 bioMérieux Company Information
- 12.9.2 bioMérieux Business Overview
- 12.9.3 bioMérieux Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.9.4 bioMérieux Mycology Immunoassays Testing Product Portfolio
- 12.9.5 bioMérieux Recent Developments
- 12.10 Beckman Coulter
- 12.10.1 Beckman Coulter Company Information
- 12.10.2 Beckman Coulter Business Overview
- 12.10.3 Beckman Coulter Revenue in Mycology Immunoassays Testing Business (2021-2026)
- 12.10.4 Beckman Coulter Mycology Immunoassays Testing Product Portfolio
- 12.10.5 Beckman Coulter Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst